gestodene has been researched along with lilopristone* in 1 studies
1 other study(ies) available for gestodene and lilopristone
Article | Year |
---|---|
Cytochrome P4503A4-mediated N-demethylation of the antiprogestins lilopristone and onapristone.
The metabolism of two newer antiprogestational agents, lilopristone and onapristone, was investigated using human liver microsomes, and evidence was obtained supporting a principal role of cytochrome P450 (CYP) 3A4 in their N-demethylations. Kinetic studies with microsomes from three organ donors indicated lack of biphasic kinetics at substrate concentrations up to 200 microM, consistent with a single enzyme mediating the oxidations. Selective chemical inhibitors of CYP1A2 (furafylline), CYP2C9 (sulfaphenazole), CYP2D6 (quinidine), and CYP2A6/2E1 (diethyldithiocarbamic acid) did not affect initial rates of metabolism of either steroid. Gestodene and triacetyloleandomycin (selective for CYP3A enzymes) inhibited the demethylations of both antiprogestins by up to 77%. Rabbit polyclonal antibodies to CYP3A4 decreased initial rates of N-demethylation of the antihormones by up to 82%, whereas antibodies to CYP2C9 were not inhibitory. Collectively, these data thus suggest potential drug-drug interactions of these promising new therapeutic agents with concomitantly administered CYP3A4 substrates. Topics: Adult; Child, Preschool; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Estrenes; Female; Gonanes; Hormone Antagonists; Humans; Male; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases; Norpregnenes; Oxidoreductases, N-Demethylating; Progestins; Troleandomycin | 1997 |